ABCB7 and anemia: Two patients presented a severe adverse event requiring their exclusion of the study: one in AS+AQ group with an increase of ASAT with a rate higher than three times the normal at day 7 and one in AL group presenting a severe anaemia, with a rate of haemoglobin less than 5g/dl at day 7.